Incyte partners with Enable Injections for drug delivery system

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Incyte partners with Enable Injections for drug delivery system

Incyte (INCY) PT Raised to $109 at BofA Securities

October 28, 2025 10:31 AM EDT

BofA Securities analyst Tazeen Ahmad raised the price target on Incyte (NASDAQ: INCY) to $109.00 (from $104.00) while maintaining a Buy rating.

The analyst comments "Incyte (INCY) reported 3Q revenues for Jakafi of $791mn (+2% q/q, ours: $774mn, cons: $773mn), Opzelura of $188mn (+6% q/q, our:... More